<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/" version="2.0">
  <channel>
    <title>Mail.com: MERCK &amp; CO. , INC.</title>
    <link>http://www.mail.com/companies/25022-merck-co-inc.html</link>
    <description>Mail.com - the best personalized free web-based Email</description>
    <language>en</language>
    <dc:language>en</dc:language>
    <image>
      <title>Mail.com: MERCK &amp; CO. , INC.</title>
      <url>http://sec-s.uicdn.com/mail.com/2.28/img/mailcom_logo_rss.png</url>
      <link>http://www.mail.com/companies/25022-merck-co-inc.html</link>
    </image>
    <item>
      <title>FDA panel backs experimental Merck insomnia drug</title>
      <link>http://www.mail.com/scitech/health/2103816-fda-panel-backs-experimental-merck-insomnia-drug.html</link>
      <description>WASHINGTON (AP) — A federal panel of medical experts said that an experimental insomnia drug from Merck &amp; Co. Inc. appears safe and effective, despite evidence from company trials that the pill can cause daytime sleepiness and difficulty driving. 
                   A majority of Food and Drug Administration panelists voted Wednesday that Merck's sleeping aid, suvorexant, he...</description>
      <pubDate>Wed, 22 May 2013 21:47:08 GMT</pubDate>
      <guid isPermaLink="false">http://www.mail.com/scitech/health/2103816-fda-panel-backs-experimental-merck-insomnia-drug.html</guid>
      <dc:date>2013-05-22T21:47:08Z</dc:date>
    </item>
    <item>
      <title>India announces low-cost rotavirus vaccine</title>
      <link>http://www.mail.com/scitech/health/2084042-india-announces-low-cost-rotavirus-vaccine.html</link>
      <description>NEW DELHI (AP) — The Indian government announced Tuesday the development of a new low-cost vaccine proven effective against a diarrhea-causing virus that is one of the leading causes of childhood deaths across the developing world. 
                   The Indian manufacturer of the new rotavirus vaccine pledged to sell it for $1 a dose, a significant discount from the cost o...</description>
      <pubDate>Tue, 14 May 2013 13:23:08 GMT</pubDate>
      <guid isPermaLink="false">http://www.mail.com/scitech/health/2084042-india-announces-low-cost-rotavirus-vaccine.html</guid>
      <dc:date>2013-05-14T13:23:08Z</dc:date>
    </item>
    <item>
      <title>Higher prices for MS drug help drug firm Merck</title>
      <link>http://www.mail.com/scitech/health/2083808-higher-prices-ms-drug-help-drug-firm-merck.html</link>
      <description>FRANKFURT, Germany (AP) — Higher prices for its multiple sclerosis drug Rebif helped German pharmaceutical and high-tech materials company Merck KGaA post a 54 percent rise in first-quarter profit. 
                   Merck also saw stronger sales of materials for liquid-crystal displays and raised its profit forecast, saying it would achieve its 2014 goals this year. Its op...</description>
      <pubDate>Tue, 14 May 2013 09:47:51 GMT</pubDate>
      <guid isPermaLink="false">http://www.mail.com/scitech/health/2083808-higher-prices-ms-drug-help-drug-firm-merck.html</guid>
      <dc:date>2013-05-14T09:47:51Z</dc:date>
    </item>
    <item>
      <title>Drugmakers, health groups bring poor girls vaccine</title>
      <link>http://www.mail.com/scitech/health/2073696-drugmakers-health-groups-bring-poor-girls-vaccine.html</link>
      <description>TRENTON, N.J. (AP) — Two multinational drugmakers are teaming up with top global health groups to protect millions of girls in the world's poorest countries from deadly cervical cancer. 
                   Starting with pilot programs in eight Asian and African nations, the ambitious project ultimately is intended to inoculate more than 30 million girls in more than 40 count...</description>
      <pubDate>Thu, 09 May 2013 13:04:42 GMT</pubDate>
      <guid isPermaLink="false">http://www.mail.com/scitech/health/2073696-drugmakers-health-groups-bring-poor-girls-vaccine.html</guid>
      <dc:date>2013-05-09T13:04:42Z</dc:date>
    </item>
    <item>
      <title>Stocks sink on economic worries; Dow off 138</title>
      <link>http://www.mail.com/business/finance/2056042-stocks-sink-economic-worries-dow-138.html</link>
      <description>NEW YORK (AP) — Signs of a slowing economy dragged down the stock market Wednesday. Even the prospect of continued stimulus from the Federal Reserve didn't help. 
                   Major market indexes fell by 0.9 percent, their worst decline in two weeks. Small-company stocks fell even more, 2.5 percent, as investors shunned risk. The yield on the benchmark U.S. government...</description>
      <pubDate>Wed, 01 May 2013 22:21:28 GMT</pubDate>
      <guid isPermaLink="false">http://www.mail.com/business/finance/2056042-stocks-sink-economic-worries-dow-138.html</guid>
      <dc:date>2013-05-01T22:21:28Z</dc:date>
    </item>
    <item>
      <title>Generic competition cuts Merck's Q1 sales, profit</title>
      <link>http://www.mail.com/business/economy/2055676-generic-competition-cuts-mercks-q1-sales-profit.html</link>
      <description>Merck &amp; Co. on Wednesday posted disappointing first-quarter results and cut its earnings forecast for the year. But the world's third-largest drugmaker predicted that things would soon improve. 
                   Merck was slammed by two factors plaguing most of its rivals: growing competition from generic drugs and unfavorable exchange rates. Major drugmakers in recent yea...</description>
      <pubDate>Wed, 01 May 2013 20:56:47 GMT</pubDate>
      <guid isPermaLink="false">http://www.mail.com/business/economy/2055676-generic-competition-cuts-mercks-q1-sales-profit.html</guid>
      <dc:date>2013-05-01T20:56:47Z</dc:date>
    </item>
    <item>
      <title>Pfizer 1Q profit up, but drugmaker cuts outlook</title>
      <link>http://www.mail.com/business/economy/2053288-pfizer-1q-profit-up-drugmaker-cuts-outlook.html</link>
      <description>Pfizer Inc.'s first-quarter net income rose 53 percent despite falling sales, mainly because the world's second-largest drugmaker took big charges a year ago. Pfizer's results fell short of Wall Street's expectations, and the company lowered its profit and sales forecasts for the year, blaming sudden worsening of currency exchange rates. 
                   Pfizer is struggl...</description>
      <pubDate>Tue, 30 Apr 2013 21:25:59 GMT</pubDate>
      <guid isPermaLink="false">http://www.mail.com/business/economy/2053288-pfizer-1q-profit-up-drugmaker-cuts-outlook.html</guid>
      <dc:date>2013-04-30T21:25:59Z</dc:date>
    </item>
    <item>
      <title>FDA probes new pancreas risks with diabetes drugs</title>
      <link>http://www.mail.com/scitech/health/1954684-fda-probes-pancreas-risks-with-diabetes-drugs.html</link>
      <description>WASHINGTON (AP) — The Food and Drug Administration is looking into new evidence that suggests a group of recently approved diabetes drugs can increase the risk of pancreatitis and other problems. 
                   The agency said Thursday samples of pancreas tissue taken from a small number of patients showed inflammation and cellular changes that often precede cancer. Aca...</description>
      <pubDate>Thu, 14 Mar 2013 20:21:27 GMT</pubDate>
      <guid isPermaLink="false">http://www.mail.com/scitech/health/1954684-fda-probes-pancreas-risks-with-diabetes-drugs.html</guid>
      <dc:date>2013-03-14T20:21:27Z</dc:date>
    </item>
    <item>
      <title>Drugmakers, Interpol ramp up fight against fakes</title>
      <link>http://www.mail.com/business/economy/1948036-drugmakers-interpol-ramp-up-fight-fakes.html</link>
      <description>More than two dozen of the world's largest pharmaceutical companies have agreed to provide funding and other support to Interpol's battle against counterfeit prescription drugs, the international police agency said Tuesday. 
                   Interpol's newly created Pharmaceutical Crime Program aims to help health agencies, police and customs bureaus in countries around th...</description>
      <pubDate>Tue, 12 Mar 2013 11:29:37 GMT</pubDate>
      <guid isPermaLink="false">http://www.mail.com/business/economy/1948036-drugmakers-interpol-ramp-up-fight-fakes.html</guid>
      <dc:date>2013-03-12T11:29:37Z</dc:date>
    </item>
    <item>
      <title>Dow surges to record ... and keeps going</title>
      <link>http://www.mail.com/business/economy/1932734-dow-surges-to-record-going.html</link>
      <description>NEW YORK (AP) — The Dow Jones industrial average closed at an all-time high Tuesday, beating the previous record it set in October 2007, before the financial crisis and Great Recession. 
                   The Dow rose 125.95 points to 14,253.77, an increase of 0.89 percent. The index jumped from the opening bell, climbed as much as 158 points early and peaked at 14,286. The...</description>
      <pubDate>Wed, 06 Mar 2013 01:03:44 GMT</pubDate>
      <guid isPermaLink="false">http://www.mail.com/business/economy/1932734-dow-surges-to-record-going.html</guid>
      <dc:date>2013-03-06T01:03:44Z</dc:date>
    </item>
    <item>
      <title>CEO: Risks key for Merck to succeed, help patients</title>
      <link>http://www.mail.com/scitech/health/1924952-ceo-risks-key-merck-to-succeed-help-patients.html</link>
      <description>NEW YORK (AP) — Merck &amp; Co. CEO Kenneth C. Frazier is convinced nearly everyone, from patients to long-term investors, wants the world's third-largest drugmaker to take big risks. 
                   So Merck is plunging ahead in one of medicine's toughest challenges — finding a drug to slow Alzheimer's disease — despite repeated failures that have led most drugmakers to hal...</description>
      <pubDate>Fri, 01 Mar 2013 17:18:26 GMT</pubDate>
      <guid isPermaLink="false">http://www.mail.com/scitech/health/1924952-ceo-risks-key-merck-to-succeed-help-patients.html</guid>
      <dc:date>2013-03-01T17:18:26Z</dc:date>
    </item>
    <item>
      <title>Bio Box: Kenneth Frazier, CEO of drugmaker Merck</title>
      <link>http://www.mail.com/business/economy/1924938-bio-box-kenneth-frazier-ceo-drugmaker-merck.html</link>
      <description>Merck &amp; Co. CEO, Chairman and President Kenneth C. Frazier 
                   AGE: 54. HOMETOWN: Philadelphia FAMILY: Married with a teenage son and adult daughter who's an engineer EDUCATION: Bachelor's degree from Pennsylvania State University; law degree from Harvard Law School 
                  
                  
                  
                   CAREER: Served in...</description>
      <pubDate>Fri, 01 Mar 2013 16:34:11 GMT</pubDate>
      <guid isPermaLink="false">http://www.mail.com/business/economy/1924938-bio-box-kenneth-frazier-ceo-drugmaker-merck.html</guid>
      <dc:date>2013-03-01T16:34:11Z</dc:date>
    </item>
    <item>
      <title>Merck settles investor suits on cholesterol drugs</title>
      <link>http://www.mail.com/scitech/health/1892112-merck-settles-investor-suits-cholesterol-drugs.html</link>
      <description>TRENTON, N.J. (AP) — Merck &amp; Co. has agreed to pay $688 million to settle two long-running lawsuits brought by investors who alleged the drugmaker delayed releasing bad news on its blockbuster cholesterol drugs to prevent a drop in sales. 
                   Merck, the world's third biggest drugmaker by revenue, said Thursday that it agreed to the settlement because it's in ...</description>
      <pubDate>Thu, 14 Feb 2013 22:21:07 GMT</pubDate>
      <guid isPermaLink="false">http://www.mail.com/scitech/health/1892112-merck-settles-investor-suits-cholesterol-drugs.html</guid>
      <dc:date>2013-02-14T22:21:07Z</dc:date>
    </item>
    <item>
      <title>Two Scouting families; opposite views on gay ban</title>
      <link>http://www.mail.com/news/world/1871148-two-scouting-families-opposite-views-gay-ban.html</link>
      <description>Despite a shared affection for Scouting, the Tessier family in Maryland and the Comers in Tennessee hope for opposite outcomes this week as leaders of the Boy Scouts of America ponder whether to move away from a national no-gays membership policy. 
                   Wes Comer, his wife and children belong to an Apostolic Pentecostal church near their Knoxville home that con...</description>
      <pubDate>Tue, 05 Feb 2013 22:35:00 GMT</pubDate>
      <guid isPermaLink="false">http://www.mail.com/news/world/1871148-two-scouting-families-opposite-views-gay-ban.html</guid>
      <dc:date>2013-02-05T22:35:00Z</dc:date>
    </item>
    <item>
      <title>US stocks close down after Dow's rally to 14,000</title>
      <link>http://www.mail.com/business/economy/1867320-us-stocks-close-dows-rally-to-14000.html</link>
      <description>Stocks hit a big milestone, then promptly spun off the road. 
                   Major indexes dived the most this year Monday, the first trading day after the Dow broke 14,000 and closed at its highest level since the financial crisis. The Dow Jones industrial average dropped as much as 143 points in afternoon trading. It closed down 129.71, or 0.9 percent, at 13,880.08. 
 ...</description>
      <pubDate>Mon, 04 Feb 2013 20:45:00 GMT</pubDate>
      <guid isPermaLink="false">http://www.mail.com/business/economy/1867320-us-stocks-close-dows-rally-to-14000.html</guid>
      <dc:date>2013-02-04T20:45:00Z</dc:date>
    </item>
    <item>
      <title>Dow ends above 14,000 for 1st time since Oct. 2007</title>
      <link>http://www.mail.com/business/economy/1861868-dow-ends-14000-1st-time-oct-2007.html</link>
      <description>NEW YORK (AP) — The Dow closed above 14,000 on Friday for the first time in more than five years. 
                   It was just a number on a board, but it was enough to raise the hopes of some investors and cause others concern about an overheated market. And it brought reminders of a different era, back before the financial crisis rocked the world economy. 
             ...</description>
      <pubDate>Fri, 01 Feb 2013 20:54:00 GMT</pubDate>
      <guid isPermaLink="false">http://www.mail.com/business/economy/1861868-dow-ends-14000-1st-time-oct-2007.html</guid>
      <dc:date>2013-02-01T20:54:00Z</dc:date>
    </item>
    <item>
      <title>Generic competition, charges cut Merck Q4 profit</title>
      <link>http://www.mail.com/business/economy/1861592-generic-competition-charges-cut-merck-q4-profit.html</link>
      <description>Merck &amp; Co.'s fourth-quarter profit fell 7 percent because of hits from generic competition and one-time charges, and the company pushed back plans for seeking approval of a key experimental osteoporosis drug. 
                   The quarterly results beat Wall Street expectations, but Merck shares fell Friday as investors learned the company is reviewing safety and efficacy...</description>
      <pubDate>Fri, 01 Feb 2013 20:09:00 GMT</pubDate>
      <guid isPermaLink="false">http://www.mail.com/business/economy/1861592-generic-competition-charges-cut-merck-q4-profit.html</guid>
      <dc:date>2013-02-01T20:09:00Z</dc:date>
    </item>
    <item>
      <title>Stocks rise on strong jobs numbers</title>
      <link>http://www.mail.com/business/economy/1861774-stocks-rise-strong-jobs-numbers.html</link>
      <description>NEW YORK (AP) — Stocks rose Friday after the latest employment report showed that the country added 157,000 jobs in January, and that hiring for the past two years was better than thought. 
                   The Dow Jones industrial average rose 87 points to 13,947. The S&amp;P 500 tacked on 5 points to 1,507. Nasdaq composite gained 20 points to 3,162. But the unemployment rat...</description>
      <pubDate>Fri, 01 Feb 2013 13:36:00 GMT</pubDate>
      <guid isPermaLink="false">http://www.mail.com/business/economy/1861774-stocks-rise-strong-jobs-numbers.html</guid>
      <dc:date>2013-02-01T13:36:00Z</dc:date>
    </item>
    <item>
      <title>Futures moving higher on strong jobs numbers</title>
      <link>http://www.mail.com/business/economy/1861524-futures-moving-higher-strong-jobs-numbers.html</link>
      <description>NEW YORK (AP) — Stock futures rose Friday after the latest employment report showed that the country added 157,000 jobs in January, and that hiring for the past two years was better than thought. 
                   Dow Jones industrial futures rose 87 points to 13,884. The broader S&amp;P futures tacked on 8.7 points to 1,502. Nasdaq futures gained 17.75 points to 2,742.75. But...</description>
      <pubDate>Fri, 01 Feb 2013 13:08:00 GMT</pubDate>
      <guid isPermaLink="false">http://www.mail.com/business/economy/1861524-futures-moving-higher-strong-jobs-numbers.html</guid>
      <dc:date>2013-02-01T13:08:00Z</dc:date>
    </item>
    <item>
      <title>Furor over proposed shift in Scouts no-gays policy</title>
      <link>http://www.mail.com/business/economy/1860372-furor-proposed-shift-scouts-no-gays-policy.html</link>
      <description>NEW YORK (AP) — The Boy Scouts of America faces intensifying criticism from the left and right over a proposal to move away from a mandatory no-gays membership policy and allow troop sponsors to decide the matter for themselves. 
                   The Human Rights Campaign, a major gay-rights group that initially welcomed the BSA's possible shift, said Thursday that it was ...</description>
      <pubDate>Thu, 31 Jan 2013 21:13:00 GMT</pubDate>
      <guid isPermaLink="false">http://www.mail.com/business/economy/1860372-furor-proposed-shift-scouts-no-gays-policy.html</guid>
      <dc:date>2013-01-31T21:13:00Z</dc:date>
    </item>
    <item>
      <title>Scouts' future uncertain if ban on gays is dropped</title>
      <link>http://www.mail.com/news/politics/1854740-scouts-future-uncertain-ban-gays-dropped.html</link>
      <description>NEW YORK (AP) — The Boy Scouts of America's proposed move away from its no-gays membership policy has outraged some longtime admirers, gratified many critics and raised intriguing questions about the iconic organization's future. 
                   Will the Scouts now be split between troops with gay-friendly policies and those that keep the ban? What will a National Jambor...</description>
      <pubDate>Tue, 29 Jan 2013 21:06:00 GMT</pubDate>
      <guid isPermaLink="false">http://www.mail.com/news/politics/1854740-scouts-future-uncertain-ban-gays-dropped.html</guid>
      <dc:date>2013-01-29T21:06:00Z</dc:date>
    </item>
    <item>
      <title>Under pressure, Boy Scouts may ease no-gays policy</title>
      <link>http://www.mail.com/news/us/1852876-under-pressure-boy-scouts-ease-no-gays-policy.html</link>
      <description>NEW YORK (AP) — Facing diverse and ceaseless protests, the Boy Scouts of America is signaling its readiness to end the nationwide exclusion of gays as scouts or leaders and give the sponsors of local troops the freedom to decide the matter for themselves. 
                   If approved by the Scouts' national executive board, possibly as soon as next week, the change would ...</description>
      <pubDate>Tue, 29 Jan 2013 10:47:00 GMT</pubDate>
      <guid isPermaLink="false">http://www.mail.com/news/us/1852876-under-pressure-boy-scouts-ease-no-gays-policy.html</guid>
      <dc:date>2013-01-29T10:47:00Z</dc:date>
    </item>
    <item>
      <title>Health care among early leaders in the S&amp;P 500</title>
      <link>http://www.mail.com/news/politics/1847012-health-care-early-leaders-sp-500.html</link>
      <description>NEW YORK (AP) — Health care stocks have started off the year on a tear. 
                   The industry group that includes health care providers, drugmakers and biotechnology companies has advanced 7.3 percent this year, making it the second-best in the Standard and Poor's 500 index, trailing only energy companies. Even drugmakers, traditionally considered a safe-haven pla...</description>
      <pubDate>Sun, 27 Jan 2013 17:48:00 GMT</pubDate>
      <guid isPermaLink="false">http://www.mail.com/news/politics/1847012-health-care-early-leaders-sp-500.html</guid>
      <dc:date>2013-01-27T17:48:00Z</dc:date>
    </item>
    <item>
      <title>Special interests gather for own inaugural parties</title>
      <link>http://www.mail.com/news/politics/1835228-special-interests-gather-inaugural-parties.html</link>
      <description>WASHINGTON (AP) — While most Americans caught distant glimpses of President Barack Obama's second inauguration festivities from their living room TVs and on the Internet, a privileged set of celebrities and special interests got pampered access Monday at exclusive soirees just blocks from the ceremonies. 
                   The parties are a January tradition, where high-pow...</description>
      <pubDate>Mon, 21 Jan 2013 19:06:00 GMT</pubDate>
      <guid isPermaLink="false">http://www.mail.com/news/politics/1835228-special-interests-gather-inaugural-parties.html</guid>
      <dc:date>2013-01-21T19:06:00Z</dc:date>
    </item>
    <item>
      <title>Merck warns docs to stop prescribing Tredaptive</title>
      <link>http://www.mail.com/scitech/health/1813646-merck-warns-docs-to-prescribing-tredaptive.html</link>
      <description>Drugmaker Merck &amp; Co. is suspending its sale of the cholesterol drug Tredaptive after initial results from a study showed that it wasn't effective and could raise the risk of some serious side effects. 
                   The Whitehouse Station, N.J., company said Friday it is telling doctors to quit prescribing the tablets, which are not approved in the United States, and i...</description>
      <pubDate>Fri, 11 Jan 2013 15:06:00 GMT</pubDate>
      <guid isPermaLink="false">http://www.mail.com/scitech/health/1813646-merck-warns-docs-to-prescribing-tredaptive.html</guid>
      <dc:date>2013-01-11T15:06:00Z</dc:date>
    </item>
    <item>
      <title>Germany's Merck suffers setback with cancer drug</title>
      <link>http://www.mail.com/scitech/health/1776020-germanys-merck-suffers-setback-with-cancer-drug.html</link>
      <description>BERLIN (AP) — German pharmaceutical company Merck KgaA says a late stage trial of a new lung cancer drug has failed to meet expectations. 
                   The company, based in Darmstadt, says the drug Stimuvax did not improve the overall survival of patients in the phase III study. Merck shares fell 3.1 percent to €98.20 ($129.41) after the announcement early Wednesday. ...</description>
      <pubDate>Wed, 19 Dec 2012 10:33:00 GMT</pubDate>
      <guid isPermaLink="false">http://www.mail.com/scitech/health/1776020-germanys-merck-suffers-setback-with-cancer-drug.html</guid>
      <dc:date>2012-12-19T10:33:00Z</dc:date>
    </item>
    <item>
      <title>New Alzheimer's drug studies offer patients hope</title>
      <link>http://www.mail.com/scitech/news/1739266-alzheimers-drug-studies-offer-patients-hope.html</link>
      <description>TRENTON, N.J. (AP) — For Alzheimer's patients and their families, desperate for an effective treatment for the epidemic disease, there's hope from new studies starting up and insights from recent ones that didn't quite pan out. 
                   If the new studies succeed, a medicine that slows or even stops progression of the brain-destroying disease might be ready in thr...</description>
      <pubDate>Mon, 03 Dec 2012 10:48:00 GMT</pubDate>
      <guid isPermaLink="false">http://www.mail.com/scitech/news/1739266-alzheimers-drug-studies-offer-patients-hope.html</guid>
      <dc:date>2012-12-03T10:48:00Z</dc:date>
    </item>
  </channel>
</rss>

